Alain Ajamian
Director
Microbiology
Biotech Umea
Sweden
Biography
Alain Ajamian joined CCG in 2012 as Director of Business Development. Prior to joining Chemical Computing Group, Alain served as Managing Director at BioChemia where he played an integral role in establishing the North American operational business. Before this, Alain was a medicinal chemist at MethylGene, now Mirati Therapeutics, where he made significant contributions to the development of HDAC and HAT inhibitors and is an inventor on several related patents.
Research Interest
Microbiology
